| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/00223980.1989.10542963 |
| P698 | PubMed publication ID | 2564435 |
| P2093 | author name string | Murray JB | |
| P2860 | cites work | Molecular pathology of schizophrenia: more than one disease process? | Q24676503 |
| Cerebral ventricular size and cognitive impairment in chronic schizophrenia | Q28263146 | ||
| The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy | Q34187608 | ||
| Thought, language, and communication disorders. I. Clinical assessment, definition of terms, and evaluation of their reliability | Q34225041 | ||
| A diagnostic interview: the schedule for affective disorders and schizophrenia | Q34269355 | ||
| Negative symptoms in schizophrenia. Definition and reliability | Q34280408 | ||
| The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders | Q35402066 | ||
| Negative and deficit symptoms in schizophrenia do respond to neuroleptics | Q38714710 | ||
| Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia | Q39255412 | ||
| Mechanism of the antipsychotic effect in the treatment of acute schizophrenia | Q39484980 | ||
| Increased dopamine-receptor sensitivity in schizophrenia | Q39498162 | ||
| Significance and meaning of neurological signs in schizophrenia | Q39626418 | ||
| The dopamine hypothesis of schizophrenia: a review | Q40550257 | ||
| A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients | Q41341617 | ||
| The dopamine hypothesis survives, but there must be a way ahead | Q41346489 | ||
| Negative symptoms: future developments of the concept | Q41395095 | ||
| Thought, language, and communication disorders. II. Diagnostic significance | Q41489106 | ||
| Negative symptoms in schizophrenia: their longitudinal course and prognostic importance | Q41503289 | ||
| The dopamine hypothesis: an overview of studies with schizophrenic patients | Q41533486 | ||
| Negative and positive symptoms in schizophrenia and depression: a followup | Q41576600 | ||
| Is modern-day schizophrenic outcome still negative? | Q41904868 | ||
| Prostaglandins, platelets, and schizophrenia | Q42450901 | ||
| Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment | Q44853637 | ||
| Cerebral ventricular size and neuropsychological impairment in young chronic schizophrenics. Measurement by the standardized Luria-Nebraska Neuropsychological Battery | Q47294659 | ||
| An international perspective on assessment of negative and positive symptoms in schizophrenia | Q47390381 | ||
| Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia | Q48181178 | ||
| The dementia of dementia praecox | Q48198288 | ||
| Increased ventricle-to-brain ratio in late-onset schizophrenia | Q48211761 | ||
| Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction | Q48518690 | ||
| Negative symptoms and platelet monoamine oxidase activity in male schizophrenic patients | Q48661775 | ||
| Lateral ventricular enlargement associated with persistent unemployment and negative symptoms in both schizophrenia and bipolar disorder | Q48674516 | ||
| Negative v positive schizophrenia. Definition and validation | Q48923421 | ||
| Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms | Q48975371 | ||
| Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. | Q51272214 | ||
| The relative stability of positive and negative features in chronic schizophrenia. | Q52076799 | ||
| The disabilities of chronic schizophrenia--their nature and the factors contributing to their development. | Q52104735 | ||
| Signs and symptoms as predictors of outcome: a report from the International Pilot Study of Schizophrenia | Q53445826 | ||
| Positive and negative schizophrenic symptoms and the role of dopamine | Q56388192 | ||
| P433 | issue | 1 | |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 69-78 | |
| P577 | publication date | 1989-01-01 | |
| P1433 | published in | The Journal of Psychology | Q7743620 |
| P1476 | title | Neuroleptic-resistant schizophrenics | |
| P478 | volume | 123 |
Search more.